Diego Anibal Dominguez
Diego Anibal Dominguez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Alejandra Weisz
Central Laboratory National Hospital Prof. Dr. Alejandro Posadas Buenos Aires Argentina
1 shared publication- Carolina Fernandez
Laboratory of Transfusion‐Transmissible Infections Regional Hemotherapy Center, Prof. Dr. Juan P. Garrahan Hospital Autonomous City of Buenos Aires Argentina
1 shared publication Claudia Nonaka
Hemotherapy Service, Department of Diagnosis and Treatment National Hospital Prof. Dr. Alejandro Posadas Buenos Aires Argentina
1 shared publicationConstanza Lapera
Laboratory of Transfusion‐Transmissible Infections Regional Hemotherapy Center, Prof. Dr. Juan P. Garrahan Hospital Autonomous City of Buenos Aires Argentina
1 shared publicationGiampaolo Scarton
BIOARS S.A, CABA, Argentina
1 shared publication- Juan Ignacio Degiuseppe
National Reference Laboratory for Norovirus and Rotavirus National Institute of Infectious Diseases (INEI), ANLIS “Dr. Carlos G. Malbrán Autonomous City of Buenos Aires Argentina
1 shared publication
Latest Publications
- 22 September 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (9) , e71157
Seroprevalence and Associated Factors of Hepatitis A Virus and Hepatitis E Virus Infection Among Blood Donors in Argentina: A Multicentre Study
Hepatitis A virus (HAV) and hepatitis E virus (HEV) are enterically transmitted hepatotropic viruses with heterogeneous epidemiological patterns in Argentina. Data simultaneously evaluating both infections in blood donor populations are limited. We conducted a multicentre cross‐sectional study including 848 blood donors from three Argentine blood banks between September 2024 and August 2025. Total antiHAV and antiHEV IgG antibodies were determined by ELISA. Sociodemographic, occupational, dietary, and donation‐related variables were collected using standardized questionnaires. Logistic regression models with restricted cubic splines were applied to assess age‐specific associations and inter‐centre variability. Overall antiHAV seroprevalence was 62.9% (95% CI: 59.6–66.0) and antiHEV seroprevalence was 12.1% (95% CI: 10.1–14.5), with significant differences between blood banks. AntiHAV seropositivity showed a non‐linear association with age and a significant interaction with blood bank ( p < 0.001), whereas no independent associations with questionnaire‐derived exposures were identified after adjustment. AntiHEV seropositivity was not associated with age but remained independently associated with occupational food handling (aOR 1.94; 95% CI: 1.04–3.51) and game meat consumption (aOR 2.19; 95% CI: 1.24–3.81). Dual seropositivity (6.5%) was consistent with statistical independence between infections. AntiHAV and antiHEV seroprevalence in this accessible adult donor population provides updated epidemiological information from three Argentine blood banks. The study also adds data on joint seroprevalence and associated factors, contributing to the understanding of HAV and HEV exposure patterns in this setting.
- 22 September 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (9) , e71157
Seroprevalence and Associated Factors of Hepatitis A Virus and Hepatitis E Virus Infection Among Blood Donors in Argentina: A Multicentre Study
Hepatitis A virus (HAV) and hepatitis E virus (HEV) are enterically transmitted hepatotropic viruses with heterogeneous epidemiological patterns in Argentina. Data simultaneously evaluating both infections in blood donor populations are limited. We conducted a multicentre cross‐sectional study including 848 blood donors from three Argentine blood banks between September 2024 and August 2025. Total antiHAV and antiHEV IgG antibodies were determined by ELISA. Sociodemographic, occupational, dietary, and donation‐related variables were collected using standardized questionnaires. Logistic regression models with restricted cubic splines were applied to assess age‐specific associations and inter‐centre variability. Overall antiHAV seroprevalence was 62.9% (95% CI: 59.6–66.0) and antiHEV seroprevalence was 12.1% (95% CI: 10.1–14.5), with significant differences between blood banks. AntiHAV seropositivity showed a non‐linear association with age and a significant interaction with blood bank ( p < 0.001), whereas no independent associations with questionnaire‐derived exposures were identified after adjustment. AntiHEV seropositivity was not associated with age but remained independently associated with occupational food handling (aOR 1.94; 95% CI: 1.04–3.51) and game meat consumption (aOR 2.19; 95% CI: 1.24–3.81). Dual seropositivity (6.5%) was consistent with statistical independence between infections. AntiHAV and antiHEV seroprevalence in this accessible adult donor population provides updated epidemiological information from three Argentine blood banks. The study also adds data on joint seroprevalence and associated factors, contributing to the understanding of HAV and HEV exposure patterns in this setting.
- 13 September 2024
- Published by Elsevier in Acta Tropica
- Vol. 260, 107395
Low-cost and simple PCR process for access to molecular diagnosis of HTLV-1/2 in low-resource countries
- 13 September 2024
- Published by Elsevier in Acta Tropica
- Vol. 260, 107395
Low-cost and simple PCR process for access to molecular diagnosis of HTLV-1/2 in low-resource countries